As Icici Bank LTD Adr (IBN) Shares Declined, Capital International Sarl Has Increased Position by $480,600; Knott David M Has Trimmed Pfizer (PFE) Holding by $1.63 Million; Stock Value Declined

April 17, 2018 - By Peter Erickson

Pfizer Inc. (NYSE:PFE) Logo

Knott David M decreased its stake in Pfizer Inc. (PFE) by 4.64% based on its latest 2017Q4 regulatory filing with the SEC. Knott David M sold 45,400 shares as the company’s stock declined 3.13% with the market. The institutional investor held 933,276 shares of the health care company at the end of 2017Q4, valued at $33.80M, down from 978,676 at the end of the previous reported quarter. Knott David M who had been investing in Pfizer Inc. for a number of months, seems to be less bullish one the $216.65B market cap company. The stock decreased 0.30% or $0.11 during the last trading session, reaching $36.42. About 8.29M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 17, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Capital International Sarl increased its stake in Icici Bank Ltd Adr (IBN) by 4.58% based on its latest 2017Q4 regulatory filing with the SEC. Capital International Sarl bought 53,400 shares as the company’s stock declined 11.13% with the market. The institutional investor held 1.22M shares of the commercial banks company at the end of 2017Q4, valued at $11.87M, up from 1.17M at the end of the previous reported quarter. Capital International Sarl who had been investing in Icici Bank Ltd Adr for a number of months, seems to be bullish on the $28.83B market cap company. The stock increased 1.78% or $0.155 during the last trading session, reaching $8.865. About 2.79M shares traded. ICICI Bank Limited (NYSE:IBN) has risen 12.06% since April 17, 2017 and is uptrending. It has outperformed by 0.51% the S&P500.

Among 7 analysts covering ICICI Bank (NYSE:IBN), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. ICICI Bank had 11 analyst reports since August 19, 2015 according to SRatingsIntel. The firm has “Sell” rating by Zacks given on Wednesday, August 19. The stock of ICICI Bank Limited (NYSE:IBN) has “Buy” rating given on Friday, October 21 by UBS. Goldman Sachs upgraded the shares of IBN in report on Monday, October 24 to “Buy” rating. On Monday, September 14 the stock rating was upgraded by Goldman Sachs to “Buy”. The firm earned “Hold” rating on Thursday, September 3 by Zacks. The company was upgraded on Thursday, April 21 by Credit Suisse. The firm has “Buy” rating given on Monday, October 30 by Jefferies. The stock of ICICI Bank Limited (NYSE:IBN) earned “Hold” rating by Standpoint Research on Wednesday, August 26. The company was downgraded on Tuesday, May 3 by Goldman Sachs. On Tuesday, August 25 the stock rating was upgraded by Zacks to “Sell”.

Capital International Sarl, which manages about $1.07 billion US Long portfolio, decreased its stake in Global Payments Inc (NYSE:GPN) by 38,600 shares to 87,915 shares, valued at $8.81M in 2017Q4, according to the filing. It also reduced its holding in Ubs Group Ag (NYSE:UBS) by 256,311 shares in the quarter, leaving it with 100,632 shares, and cut its stake in Schlumberger Ltd (NYSE:SLB).

Knott David M, which manages about $251.42 million US Long portfolio, upped its stake in Macquarie Infrastructure Corporation (NYSE:MIC) by 120,000 shares to 132,300 shares, valued at $8.49 million in 2017Q4, according to the filing.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $43.0 target in Monday, September 18 report. Jefferies maintained the shares of PFE in report on Thursday, July 14 with “Buy” rating. SunTrust upgraded Pfizer Inc. (NYSE:PFE) on Wednesday, November 25 to “Neutral” rating. The stock has “Sell” rating by Citigroup on Tuesday, May 16. The stock has “Neutral” rating by Goldman Sachs on Monday, April 18. Morgan Stanley maintained the stock with “Overweight” rating in Wednesday, January 31 report. The rating was maintained by Cowen & Co on Monday, August 14 with “Buy”. The stock of Pfizer Inc. (NYSE:PFE) earned “Market Perform” rating by BMO Capital Markets on Wednesday, November 2. Piper Jaffray maintained it with “Buy” rating and $54.0 target in Thursday, September 14 report. Jefferies maintained the shares of PFE in report on Tuesday, September 13 with “Buy” rating.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Bartlett And Ltd Limited Liability Company has 0.24% invested in Pfizer Inc. (NYSE:PFE). Quantres Asset Management Ltd has 0.77% invested in Pfizer Inc. (NYSE:PFE). Moreover, Mcrae Management has 1.13% invested in Pfizer Inc. (NYSE:PFE). Tudor Inv Et Al has 0.02% invested in Pfizer Inc. (NYSE:PFE). Trexquant Invest Limited Partnership reported 0.1% stake. Camarda Advsr holds 25,289 shares. Diversified Tru accumulated 24,553 shares. Polar Llp has invested 0.68% in Pfizer Inc. (NYSE:PFE). Atria Invs Limited Liability Company has 0.42% invested in Pfizer Inc. (NYSE:PFE). Benchmark Cap Advsr reported 2.83% of its portfolio in Pfizer Inc. (NYSE:PFE). Eaton Vance Mngmt has 0.76% invested in Pfizer Inc. (NYSE:PFE) for 8.68 million shares. 50,913 were accumulated by Arcadia Mngmt Corporation Mi. Lpl Financial Ltd Llc has 0.17% invested in Pfizer Inc. (NYSE:PFE) for 1.58 million shares. Institute For Wealth Mngmt Limited Liability Company stated it has 42,186 shares. Foster Dykema Cabot Inc Ma reported 20,380 shares stake.

Since December 15, 2017, it had 0 insider purchases, and 12 selling transactions for $12.99 million activity. Shares for $986,292 were sold by HILL CHARLES H. 27,323 Pfizer Inc. (NYSE:PFE) shares with value of $998,666 were sold by JOHNSON RADY A. LUND-JURGENSEN KIRSTEN had sold 9,510 shares worth $353,677. On Friday, March 9 the insider Dolsten Mikael sold $2.55 million. Shares for $1.84M were sold by LANKLER DOUGLAS M. $64,679 worth of Pfizer Inc. (NYSE:PFE) shares were sold by CORNWELL W DON.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.47 P/E if the $0.73 EPS becomes a reality. After $0.62 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: